옵션
AI 프롬프트 목록 철학/종교 윤리적 의사결정 지원

윤리적 의사결정 지원

{:__('collect %s',윤리적 의사결정 지원)}

비즈니스 운영의 도덕적 딜레마에 대해 공리주의와 의무론에 기반한 균형 잡힌 분석을 제공하여 관리자가 규정 준수 및 사회적 책임을 고려한 결정을 내리도록 지원합니다.

프롬프트 내용 복사 복사

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.

복사 복사

기업 윤리 컨설턴트로서 다음 구체적인 비즈니스 시나리오를 분석하십시오: 제약 회사가 장기 사용 시 경미하지만 충분히 공개되지 않은 부작용이 있는 베스트셀러 의약품을 발견했습니다. 판매를 계속하면 이익은 증가하지만 일부 환자에게 해를 끼칠 수 있으며, 리콜하면 막대한 손실과 해고를 초래합니다. 공리주의에 따른 전반적인 복지에 대한 영향과 의무론에 따른 정직한 공개의 의무 강조를 결합하여 두 경로의 도덕적 무게를 평가하고, 법적 준수, 기업 생존, 사회적 책임을 고려한 균형 잡힌 권장 사항을 제공하십시오. 절대적인 도덕적 판단을 피하고 이해관계자 분석에 기반한 의사결정 프레임워크를 제공하십시오.

복사 복사
의견 (0)
0/300

추천

윤리적 의사결정 지원
Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.
윤리적 의사결정 지원
Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.
윤리적 의사결정 지원
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.
윤리적 의사결정 지원
Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.
윤리적 의사결정 지원
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.
윤리적 의사결정 지원
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.
OR